Rgenta Therapeutics
Jon Dempersmier is a seasoned scientist with extensive experience in the field of biochemistry and cancer research. Currently serving as a Senior Scientist at Rgenta Therapeutics Inc. since September 2022, Jon's previous roles include Scientist II at the Dana-Farber Cancer Institute from June 2018 to September 2022 and Postdoctoral Fellow at the same institution. Educationally, Jon earned a Doctor of Philosophy (Ph.D.) in Comparative Biochemistry from the University of California, Berkeley, where Jon also completed a postdoctoral research position. Additionally, Jon holds a Bachelor of Science (B.S.) in Chemistry from the University of Montana and has experience as an Undergraduate Research Assistant.
This person is not in any offices
Rgenta Therapeutics
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.